Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Degarelix
Degarelix
Inquiry
| Post Date: | Jan 14,2020 |
| Expiry Date: | Jan 13,2021 |
| Detailed Description: |
Cas No. :214766-78-6
Quantity: 1 Price:1 USD Metric Tons Payment Method: T/T in advance CAS Number: 214766-78-6 Molecular formula : C82H103N18O16Cl Molar mass :1632.26 Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(Hor)-D-4Aph(Cbm)-Leu-ILys-Pro-D-Ala-NH2 Sequence Medical use: Degarelix has an immediate onset of action, binding to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocking their interaction with GnRH. Degarelix is a hormonal therapy used in the treatment of advanced prostate cancer. |
| CAS Registry Number: | 214766-78-6 |
| Synonyms: | ;Degarelix;Firmagon;D-Alaninamide,N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-ly; |
| Molecular Formula: | C82H103ClN18O16 |
| Molecular Weight: | 1632.28 |
| Molecular Structure: | 
|
| Company: | Shenzhen JYMed Technology Co.,Ltd. [ China ] |
| Contact: | Jason |
| Tel: | +8613760789805 |
| Fax: | +(86) 0755-86350488 |
| Email: | wucx@jymed.cn |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
